当前位置: 首页 >> 检索结果
共有 16257 条符合本次的查询结果, 用时 2.706478 秒

261. The devastating effect of abrupt US refugee policy shifts.

作者: Mustafa Rfat.;Ashley Cureton.;Mansha Mirza.;Jean-Francois Trani.
来源: Lancet. 2025年405卷10486期1225页

262. Unheard harms to LGBTQ+ patients and scientists.

作者: Cass Condray.
来源: Lancet. 2025年405卷10486期1225-1226页

263. The USA and the plight of children in a humanitarian crisis.

作者: Lola Ayanda.;Tricia Young.
来源: Lancet. 2025年405卷10486期1224页

264. A taste of your own medicine: the experience of a transplant.

作者: Havi Carel.
来源: Lancet. 2025年405卷10486期1220-1221页

265. Accelerating domestic investments to end AIDS in Africa.

作者: Michel Sidibe.;Thabo Cecil Makgoba.;Bishop Paul.;Barbara Brilliant.;Joshua H K Banda.;Martha Sichone Cameron.;Nelson Makanda.;Vuyelwa Sidile Chitimbire.;Gibstar Makangila.;Nkatha Njeru.;Esther Mombo.
来源: Lancet. 2025年405卷10487期1335-1336页

266. Measles: the urgent need for global immunisation and preparedness.

作者: Krutika Kuppalli.;Saad B Omer.
来源: Lancet. 2025年405卷10489期1565-1567页

267. Protecting Africa's children from extreme risk: a runway of sustainability for PEPFAR programmes.

作者: Lucie Cluver.;Gibstar Makangila.;Susan Hillis.;Joel-Pascal Ntwali-N'Konzi.;Seth Flaxman.;Juliette Unwin.;Jeffrey W Imai-Eaton.;Vuyelwa Chtimbire.;Lorraine Sherr.;Jane Ng'ang'a.;Chris Desmond.;Elona Toska.;Olayinka Omigbodun.;Oliver Ratmann.;Galen Carey.;Mary Mahy.;Brian Honermann.;John Stover.
来源: Lancet. 2025年405卷10490期1700-1712页
PEPFAR (President's Emergency Plan for AIDS Relief), a landmark US foreign health policy, is recognised for saving 26 million lives from HIV. PEPFAR investments have also had life-saving impacts for children across sub-Saharan Africa through childhood HIV prevention, care, and treatment, ensuring 7·8 million babies were born HIV-free, supporting 13 million orphaned and vulnerable children, and protecting 10·3 million girls from sexual abuse. In this Health Policy, we review data from UNAIDS, UNICEF, World Bank, Violence Against Children Surveys, SPECTRUM model data, and Population-based HIV Impact Assessments; synthesise PEPFAR reports; conduct in-depth interviews; search PubMed for programme effectiveness evidence; and review economic reports. PEPFAR support is associated with substantial collateral benefits for the USA and Africa, including a four-fold increase in export of US goods to Africa, and US$71·6 billion in total goods trade between the USA and Africa in 2024. PEPFAR-supported countries in Africa are committed to ownership of HIV responses by 2030-overall, PEPFAR-supported countries in sub-Saharan Africa have progressively increased their co-financing of their health systems through domestic government and private expenditure from $13·7 billion per year in 2004 to $42·6 billion per year in 2021. The feasibility of a 5-year transition to country-led sustainability is supported by evidence of innovative cost-saving models of delivery, including through faith-based and community-based organisations, and high return-on-investment for PEPFAR programmes. There are also collateral benefits of PEPFAR for US and Africa national security and health security, for example, reducing forced migration and increasing capacity to control emerging transborder infectious disease threats. Risks in sub-Saharan Africa remain acute: one in five girls (younger than 18 years) experience rape or sexual assault; one in ten children (younger than 18 years) are orphaned; and a child (younger than 15 years) is estimated to die from AIDS every 7 min. Without continued PEPFAR programmes, models predict that by 2030, an additional 1 million children will become infected with HIV, 0·5 million additional children will die of AIDS, and 2·8 million children will additionally become orphaned by AIDS. There is now an opportunity for a transformational partnership between the USA and Africa, to accelerate domestic government co-financing, private-sector investments, and charitable foundations. A 5-year progressive runway of transition can occur through continued authorisation of PEPFAR programmes, which can lead to the end of AIDS for children and families, an historic achievement.

268. Raewyn Connell: influential gender theorist.

作者: Tony Kirby.
来源: Lancet. 2025年

269. Gender and global health: going, going, but not gone.

作者: Sarah Hawkes.;Raewyn Connell.;Jocalyn Clark.;Jeni Klugman.;Gary L Darmstadt.;Erica Nelson.;Amy Chiaying Hsieh.;Elhadj As Sy.;Gary Barker.;Beniamino Cislaghi.;Kent Buse.
来源: Lancet. 2025年405卷10487期1317-1320页

270. Achieving gender justice for global health equity: the Lancet Commission on gender and global health.

作者: Sarah Hawkes.;Elhadj As Sy.;Gary Barker.;Frances Elaine Baum.;Kent Buse.;Angela Y Chang.;Beniamino Cislaghi.;Jocalyn Clark.;Raewyn Connell.;Morna Cornell.;Gary L Darmstadt.;Carmen Simone Grilo Diniz.;Sharon Friel.;Indrani Gupta.;Sofia Gruskin.;Sarah Hill.;Amy Chiaying Hsieh.;Renu Khanna.;Jeni Klugman.;Aaron Koay.;Vivian Lin.;Khadija T Moalla.;Erica Nelson.;Lynsey Robinson.;Nina Schwalbe.;Ravi Verma.;Virginia Zarulli.
来源: Lancet. 2025年405卷10487期1373-1438页

271. Standing up for gender justice.

作者: The Lancet.
来源: Lancet. 2025年405卷10487期1313页

272. Elhadj As Sy: global health leader and advocate for gender justice.

作者: Udani Samarasekera.
来源: Lancet. 2025年405卷10487期1330页

273. Tuberculosis: a threat to health security in the European region and the collective actions needed.

作者: Hans Henri P Kluge.
来源: Lancet. 2025年405卷10488期1450-1452页

274. Why we need to stop talking about productivity in the NHS.

作者: Jessamy Bagenal.
来源: Lancet. 2025年405卷10487期1324-1325页

275. Advancing health-care equity for autistic people: mental health as a key priority.

作者: Daniel L Wechsler.;William Mandy.;Meng-Chuan Lai.;Brian Boyd.;Matthew S Goodwin.;Gauri Divan.;Virginia Carter Leno.
来源: Lancet. 2025年405卷10491期1723-1726页

276. Protecting global sexual and reproductive health and rights in the face of retrograde US policies and positions.

作者: Susheela Singh.;Gilda Sedgh.;Elizabeth A Sully.;Onikepe Owolabi.;Jonathan Wittenberg.
来源: Lancet. 2025年405卷10490期1650-1653页

277. Mobilising national and regional assets and non-state actors for pandemic preparedness.

作者: Louisa Sun.;Duncan Selbie.;Ali S Khan.;Salim S Abdool Karim.;Helena Legido-Quigley.;Folasade T Ogunsola.;Gwendolen Eamer.;Malebona Precious Matsoso.;Daniel G Bausch.;Dale Fisher.
来源: Lancet. 2025年405卷10487期1320-1324页

278. Causes of and risk factors for postpartum haemorrhage: a systematic review and meta-analysis.

作者: Idnan Yunas.;Md Asiful Islam.;Kulandaipalayam N Sindhu.;Adam J Devall.;Marcelina Podesek.;Sayeda Sadia Alam.;Shoumik Kundu.;Kristie-Marie Mammoliti.;Ashraf Aswat.;Malcolm J Price.;Javier Zamora.;Olufemi T Oladapo.;Ioannis Gallos.;Arri Coomarasamy.
来源: Lancet. 2025年405卷10488期1468-1480页
An understanding of the causes of postpartum haemorrhage is needed to provide appropriate treatment and services. Knowledge of the risk factors for postpartum haemorrhage can help address modifiable risk factors. We did a systematic review and meta-analysis to identify and quantify the various causes and risk factors for postpartum haemorrhage.

279. Weighing up causes of and risk factors for postpartum haemorrhage to improve its prevention.

作者: Anne-Sophie Ducloy-Bouthors.;Maria-Fernanda Escobar Vidarte.
来源: Lancet. 2025年405卷10488期1440-1441页

280. The promise and compromise of the WHO Pandemic Agreement for spillover prevention and One Health.

作者: Alexandra Finch.;Neil M Vora.;Latiffah Hassan.;Chris Walzer.;Raina K Plowright.;Robyn Alders.;Chyna Yong Suit-B.;John H Amuasi.;Moses Mulumba.;Ted Loch-Temzelides.;Sergio Guerrero-Sanchez.;Lawrence O Gostin.
来源: Lancet. 2025年405卷10492期1800-1802页
共有 16257 条符合本次的查询结果, 用时 2.706478 秒